SPOTLIGHT: CDC: Recalled drug sickens 50

In the wake of Baxter's recall of several batches of its heparin blood thinner, the Centers for Disease Control and Prevention has announced that more than 50 dialysis patients in 12 states have had allergic reactions, probably due to the drug. Report

Suggested Articles

More than a year after J&J and Bayer pulled the plug on Xarelto in patients after a rare valve replacement, the pair are still seeking answers.

Novartis hopes to leverage its existing presence in the hematology community to achieve a successful launch of Adakveo.

AstraZeneca's Farxiga is touting its heart failure data in patients with or without diabetes, but results in non-diabetics looks particularly strong.